A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
Clinical trial NCT05619744 · COMPLETED
Trial details
- NCT number
- NCT05619744
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2025-03-04
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.